Journal profile · UROLOGY & NEPHROLOGY
Kidney International Supplements
ISSN 2157-1724 · eISSN 2157-1716 · Elsevier Inc. · UNITED STATES
Kidney International Supplements: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 7.11; subscription journal; APC about USD 3,500; 5 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Kidney International Supplements is published by Elsevier Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes and Diverse Scientific and Economic Studies, together about 38.7% of its articles. Its main subfields are Nephrology. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the International Society of NephrologyKidney International SupplementsTM is published on behalf of the International Society of Nephrology (ISN) and comes complimentary as part of a subscription to Kidney International. Kidney International SupplementsTM is a peer-reviewed journal whose focus is sponsored, topical content of interest to the nephrology community.If you would like access to KI Supplements, please subscribe to Kidney International.
From the journal's Aims & Scope
Research area (LetPub): UROLOGY & NEPHROLOGY
Editorial board by country: 5 in mainland China (about 3%); most named United States 75, Germany 18, Australia 14, France 13, Japan 12 (191 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Dialysis and Renal Disease ManagementMedicine16.1%
- Chronic Kidney Disease and DiabetesMedicine14%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance8.7%
- Human auditory perception and evaluationEngineering5.3%
- Renal Diseases and GlomerulopathiesMedicine5.1%
- Educational Robotics and EngineeringComputer Science5%
- Blood Pressure and Hypertension StudiesMedicine4.8%
- Renal Transplantation Outcomes and TreatmentsMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Urology & Nephrology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Urology & Nephrology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Urology & Nephrology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 7.11LetPub ·
- Impact factor (publisher)
- 8.3Publisher website ·
- CiteScore 2026-06
- 117.7LetPub ·
- CiteScore (publisher)
- 117.7Publisher website ·
- SJR 2026-06
- 12.37LetPub ·
- SNIP 2026-06
- 27.11LetPub ·
- h-index
- 24LetPub ·
- h-index
- 69OpenAlex ·
- i10-index
- 224OpenAlex ·
- 2-year mean citedness
- 6.77OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 390 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 10 | 10 | 15 |
| 2025 | 5 | 5 | 10 |
| 2024 | 16 | 14 | 185 |
| 2022 | 13 | 13 | 3,307 |
| 2021 | 27 | 27 | 649 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 5 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance to publication
- 159 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,500 / EUR 3,270 / GBP 2,800 / JPY 434,110 | — | — | |
| Publisher website | USD 3,650 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- supplement articlesSupplement manuscripts must be prepared and submitted according to the Guide for Authors.Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, Open access, Peer review, Preprints
- Authorship Authorship
Requirements for all categories of articles should conform to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," developed by the ICMJE (https://www.icmje.org).Each author must have contributed sufficiently to the intellectual content of the submission. The corresponding author should list all authors and their contributions to the work. The corresponding author must conf…
Source ↗Publisher website ·- Conflicts of interest Disclosures/conflicts of interest
The supplement must include a statement indicating the source(s) of funding. All authors should disclose what, if any, financial relationship they have with the sponsor of the supplement, or the manufacturer of any products, or competing products, that are discussed in their manuscripts. Each manuscript must indicate any support that was obtained for the manuscript or its contents. If medical writ…
Source ↗Publisher website ·- Publication ethics
COPE member Model summary
This journal is a member of, and subscribes to the principles of, the Committee on Publications Ethics (COPE) http://www.publicationethics.org.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Supplement peer review
Single blind peer review Model summary
Kidney International Supplements operates a single blind peer review process coordinated by the Editor-in-Chief or an Associate Editor. All supplement articles undergo review of their contents by at least one external peer reviewer. The Editor-in-Chief reserves the right to reject portions of the supplement or the entire supplement. The editorial office will contact the Guest Editor or Coordinator…
Source ↗Publisher website ·- Preprints Preprint references
Preprint referencing policy Model summary
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier Inc.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2157-1724
- Electronic ISSN
- 2157-1716
- Society / sponsor
- International Society of Nephrology
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Kidney International Supplements
What CAS zone is Kidney International Supplements in?
In the 2025 upgraded edition of the CAS Journal Ranking, Kidney International Supplements is in Zone 2 of Medicine, and in Zone 2 of the minor category Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Kidney International Supplements?
The latest impact factor listed by LetPub is 7.11; CiteScore 117.7, h-index 69.
Where are the editorial board members of Kidney International Supplements based?
Of the 191 board members whose country the journal's board page names, 5 (about 3%) are in mainland China; the countries named most often are United States (75), Germany (18) and Australia (14). Counted from the institutions listed on the board page; for reference only.
Which databases index Kidney International Supplements?
According to LetPub and DOAJ records, Kidney International Supplements is indexed in SCIE and Scopus.
Is Kidney International Supplements open access, and what is the APC?
Kidney International Supplements is a subscription journal. APC about USD 3,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .